2020
DOI: 10.1111/tid.13503
|View full text |Cite
|
Sign up to set email alerts
|

Organ recovery from deceased donors with prior COVID‐19: A case series

Abstract: Although guidance documents have been published regarding organ donation from individuals with a prior history of COVID‐19 infection, no data exist regarding successful recovery and transplantation from deceased donors with a history of or positive testing suggesting a prior SARS‐CoV‐2 infection. Here, we report a case series of six deceased donors with a history of COVID‐19 from whom 13 organs were recovered and transplanted through several of the nation's organ procurement organizations (OPOs). In addition, … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

2
56
0
4

Year Published

2021
2021
2024
2024

Publication Types

Select...
8
1
1

Relationship

0
10

Authors

Journals

citations
Cited by 50 publications
(64 citation statements)
references
References 20 publications
(22 reference statements)
2
56
0
4
Order By: Relevance
“…Multiple cases have now been reported using organs from SARS‐CoV‐2 RNA‐positive donors with prior documented and resolved infection. 26 The cycle threshold, an inverse correlate with the viral load, may help determine the likelihood of productive infection (either extremely early or late in infection) but is not available from many SARS‐CoV‐2 RNA testing platforms and was not available in time to influence clinical decisions for most of these donors. SARS‐CoV‐2 serology may also aid in assessing acute or resolved infection but the commercial tests, authorized under emergency use, have not been well validated for clinical use.…”
Section: Discussionmentioning
confidence: 99%
“…Multiple cases have now been reported using organs from SARS‐CoV‐2 RNA‐positive donors with prior documented and resolved infection. 26 The cycle threshold, an inverse correlate with the viral load, may help determine the likelihood of productive infection (either extremely early or late in infection) but is not available from many SARS‐CoV‐2 RNA testing platforms and was not available in time to influence clinical decisions for most of these donors. SARS‐CoV‐2 serology may also aid in assessing acute or resolved infection but the commercial tests, authorized under emergency use, have not been well validated for clinical use.…”
Section: Discussionmentioning
confidence: 99%
“…Therefore, further monitoring of the recipients is needed. This may help to improve the current understanding of the impacts of the pandemic on transplantation practices 14 …”
Section: Discussionmentioning
confidence: 99%
“…Previously there have been reports of transplantation from a deceased donor who had a history of COVID‐19. 14 , 15 The prime difference in our report is the fact that COVID‐19 was the actual cause of death in our report. Abandoning deceased donor kidney transplantation in will resulted in the wastage of organs and further extension of wait listing in patients.…”
mentioning
confidence: 59%